Refuting the net risks test: a response to Wendler and Miller's "Assessing research risks systematically"
Graduate studies at Western
Journal of Medical Ethics 33 (8):487-490 (2007)
|Abstract||Earlier in the pages of this journal (p 481), Wendler and Miller offered the "net risks test" as an alternative approach to the ethical analysis of benefits and harms in research. They have been vocal critics of the dominant view of benefit-harm analysis in research ethics, which encompasses core concepts of duty of care, clinical equipoise and component analysis. They had been challenged to come up with a viable alternative to component analysis which meets five criteria. The alternative must (1) protect research subjects; (2) allow clinical research to proceed; (3) explain how physicians may offer trial enrolment to their patients; (4) address the challenges posed by research containing a mixture of interventions and (5) define ethical standards according to which the risks and potential benefits of research may be consistently evaluated. This response argues that the net risks test meets none of these criteria and concludes that it is not a viable alternative to component analysis|
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
|Through your library||Configure|
Similar books and articles
D. Wendler & F. G. Miller (2007). Assessing Research Risks Systematically: The Net Risks Test. Journal of Medical Ethics 33 (8):481-486.
Annette Rid & David Wendler (2011). A Framework for Risk-Benefit Evaluations in Biomedical Research. Kennedy Institute of Ethics Journal 21 (2):141-179.
Charles Weijer & Paul B. Miller, When Are Research Risks Reasonable in Relation to Anticipated Benefits?
David Wendler (2012). A New Justification for Pediatric Research Without the Potential for Clinical Benefit. American Journal of Bioethics 12 (1):23 - 31.
Alexander Friedman, Emily Robbins & David Wendler (2012). Which Benefits of Research Participation Count as 'Direct'? Bioethics 26 (2):60-67.
Charles Weijer, The Ethical Analysis of Risks and Potential Benefits in Human Subjects Research: History, Theory, and Implications for U.S. Regulation.
Andrew D. McRae & Charles Weijer, Lessons From Everyday Lives: A Moral Justification for Acute Care Research.
David Wendler (2005). Protecting Subjects Who Cannot Give Consent: Toward a Better Standard for "Minimal" Risks. Hastings Center Report 35 (5):37-43.
David Wendler & Emily Abdoler (2011). Does It Matter Whether Investigators Intend to Benefit Research Subjects? Kennedy Institute of Ethics Journal 20 (4):353-370.
Paul B. Miller & Charles Weijer (2007). Equipoise and the Duty of Care in Clinical Research: A Philosophical Response to Our Critics. Journal of Medicine and Philosophy 32 (2):117 – 133.
David B. Resnik (2012). Responsible Conduct in Nanomedicine Research: Environmental Concerns Beyond the Common Rule. Journal of Law, Medicine and Ethics 40 (4):848-855.
Janet Malek (2007). Understanding Risks and Benefits in Research on Reproductive Genetic Technologies. Journal of Medicine and Philosophy 32 (4):339 – 358.
Added to index2010-09-08
Total downloads5 ( #170,343 of 738,868 )
Recent downloads (6 months)1 ( #61,778 of 738,868 )
How can I increase my downloads?